For me, you can’t have 4 phase 2 assets that are fully funded to complete trials with significant news due in 12 months and be below $40Mn market cap. The CEO issue is not yet a deal breaker for me although he is paid too high ($700k) for a microcap. But when we become a mid cap and his pay stays the same, then it would be about right.
At 10X from here we would still be a small cap, so there is plenty of growth in this story.
AIMO. DYOR.
SNT - General Discussions, page-18
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.001(2.86%) |
Mkt cap ! $43.87M | |||
| Open | High | Low | Value | Volume |
| 3.5¢ | 3.5¢ | 3.4¢ | $14.00K | 402.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 440288 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 374403 | 3 |
View Market Depth
| Last trade - 15.50pm 30/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |